Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AquaBounty Technologies, Inc. (AQB : NSDQ)
 
 • Company Description   
AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States.

Number of Employees: 95

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.32 Daily Weekly Monthly
20 Day Moving Average: 644,348 shares
Shares Outstanding: 71.11 (millions)
Market Capitalization: $93.87 (millions)
Beta: 1.24
52 Week High: $6.53
52 Week Low: $1.13
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.58% -1.55%
12 Week -8.33% 0.77%
Year To Date -37.14% -24.36%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2 MILL & MAIN PLACE SUITE 395
-
MAYNARD,MA 01754
USA
ph: 978-648-6000
fax: -
investors@aquabounty.com http://www.aquabounty.com
 
 • General Corporate Information   
Officers
Sylvia A. Wulf - President; Chief Executive Officer and Director
Richard J. Clothier - Chairman of the Board; Director
David A. Frank - Chief Financial Officer and Treasurer
Christine St.Clare - Director
Rick Sterling - Director

Peer Information
AquaBounty Technologies, Inc. (CORR.)
AquaBounty Technologies, Inc. (RSPI)
AquaBounty Technologies, Inc. (CGXP)
AquaBounty Technologies, Inc. (BGEN)
AquaBounty Technologies, Inc. (GTBP)
AquaBounty Technologies, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 03842K200
SIC: 900
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 71.11
Most Recent Split Date: (:1)
Beta: 1.24
Market Capitalization: $93.87 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.39 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.45
Price/Cash Flow: -
Price / Sales: 45.50
EPS Growth
vs. Year Ago Period: -16.67%
vs. Previous Quarter: 12.50%
Sales Growth
vs. Year Ago Period: 1,201.35%
vs. Previous Quarter: 130.38%
ROE
03/31/22 - -10.71
12/31/21 - -10.01
09/30/21 - -11.24
ROA
03/31/22 - -10.12
12/31/21 - -9.49
09/30/21 - -10.64
Current Ratio
03/31/22 - 43.90
12/31/21 - 32.79
09/30/21 - 75.90
Quick Ratio
03/31/22 - 43.50
12/31/21 - 32.58
09/30/21 - 75.44
Operating Margin
03/31/22 - -1,128.26
12/31/21 - -1,901.45
09/30/21 - -2,764.14
Net Margin
03/31/22 - -1,128.26
12/31/21 - -1,901.45
09/30/21 - -2,764.14
Pre-Tax Margin
03/31/22 - -1,128.26
12/31/21 - -1,899.83
09/30/21 - -2,775.56
Book Value
03/31/22 - 2.94
12/31/21 - 3.01
09/30/21 - 3.09
Inventory Turnover
03/31/22 - 7.34
12/31/21 - 5.96
09/30/21 - 5.94
Debt-to-Equity
03/31/22 - 0.04
12/31/21 - 0.04
09/30/21 - 0.04
Debt-to-Capital
03/31/22 - 3.87
12/31/21 - 3.83
09/30/21 - 3.80
 

Powered by Zacks Investment Research ©